tagraxofusp

Italy

Drugs containing this active substance

  • ELZONRIS

    This medicine is used to treat adults with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare type of cancer that affects immune cells and can involve organs such as the skin, bone marrow, and lymph nodes.

    Form: solution for infusion, concentrate

    Active substance Dosage
    tagraxofusp -

    ATC: L01XX67

    Manufacturer: STEMLINE THERAPEUTICS BV